Direkt zum Inhalt
Merck

Y0000468

Brotizolam

European Pharmacopoeia (EP) Reference Standard

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

Empirische Formel (Hill-System):
C15H10BrClN4S
CAS-Nummer:
Molekulargewicht:
393.69
UNSPSC-Code:
41116107
NACRES:
NA.24
Preise und Verfügbarkeit sind derzeit nicht verfügbar.

Qualität

pharmaceutical primary standard

API-Familie

brotizolam

Hersteller/Markenname

EDQM

drug control

psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

Lagertemp.

2-8°C

SMILES String

[s]1c2c(cc1Br)C(=NCc4[n]2c(nn4)C)c3c(cccc3)Cl

InChI

1S/C15H10BrClN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3

InChIKey

UMSGKTJDUHERQW-UHFFFAOYSA-N

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Brotizolam EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

T Osanai et al.
British journal of clinical pharmacology, 58(5), 476-481 (2004-11-04)
To assess the effect of itraconazole, a potent inhibitor of cytochrome P450 (CYP)3A4, on the single oral dose pharmacokinetics and pharmacodynamics of brotizolam. In this randomized, double-blind, cross-over trial 10 healthy male subjects received either itraconazole 200 mg or matched
Tomoki Nishiyama et al.
Journal of anesthesia, 21(1), 7-12 (2007-02-08)
The purpose of this study was to evaluate the effects of quazepam, a long-acting hypnotic, as a preoperative night medication in comparison with brotizolam, a shortacting hypnotic. Two hundred patients (aged 30 to 70 years) admitted for elective general anesthesia
Paradoxical reactions to hypnotic agents in adolescents with free-running disorder.
Masaru Echizenya et al.
Psychiatry and clinical neurosciences, 63(3), 428-428 (2009-07-02)
Akshay Anand et al.
Behavioural brain research, 182(1), 12-20 (2007-06-15)
Benzodiazepines such as diazepam, lorazepam, are reported to produce anterograde amnesia but these do not affect the retrieval mechanism. Triazodiazepines such as alprazolam, triazolam and brotizolam produce both anterograde and retrograde amnesia. Because benzodiazepine receptor antagonists are known to reverse
Yukihiro Ujiie et al.
Therapeutic drug monitoring, 28(3), 299-302 (2006-06-17)
The purpose of the present study was to examine the effects of rifampicin on the single oral dose pharmacokinetics and pharmacodynamics of brotizolam. Thirteen healthy male volunteers received rifampicin 450 mg/day, or matched placebo, for 7 days in a double-blind

Fragen

Bewertungen

Kein Beurteilungswert

Aktive Filter

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.